VRTX insider trading
Vertex Pharmaceuticals Incorporated · end-of-day data as of Oct 16, 2026
Vertex Pharmaceuticals Incorporated
$499.74+4.7%
Buy · 33 analystsPT $569.95 +14.0%
In the last 12 months VRTX insiders made 0 open-market purchases and 57 sales worth $158M, as reported on SEC Form 4. The latest: McKechnie Duncan (officer: EVP, Chief Commercial Officer) sold 1,541 shares at $519.00 on Jul 2, 2026.
Last 90 days
- InsidersNone in 90d
Transactions
Open-market buys $0 · sells $158M over the last 365 days (0 buys, 57 sells).
| Sep 8, 2026 | van Grunsven Jasper | Other | 8,682 | — | — |
| Aug 28, 2026 | Ambrose Kristen | Other | 5,000 | — | — |
| Aug 27, 2026 | SACHS BRUCE I | Other | 6,000 | — | — |
| Jul 21, 2026 | Sachdev Amit | Other | 8,251 | — | — |
| Jul 21, 2026 | Tatsis Ourania | Other | 8,251 | — | — |
| Jul 15, 2026 | Garber Alan M | Other | 32 | — | — |
| Jul 15, 2026 | SACHS BRUCE I | Other | 100 | — | — |
| Jul 2, 2026 | McKechnie Duncan | Sell | 1,541 | $519.00 | $800K |
| Jul 2, 2026 | Tatsis Ourania | Sell | 1,500 | $524.99 | $787K |
| Jul 1, 2026 | Liu Joy | Sell | 828 | $502.71 | $416K |
| Jun 26, 2026 | Bozic Carmen | Sell | 596 | $482.50 | $288K |
| Jun 18, 2026 | Bozic Carmen | Sell | 1,020 | $462.17 | $471K |
| Jun 15, 2026 | Bozic Carmen | Sell | 4,062 | $450.00 | $1.83M |
| Jun 5, 2026 | Bozic Carmen | Sell | 1,745 | $450.00 | $785K |
| May 29, 2026 | Bozic Carmen | Sell | 1,974 | $450.00 | $888K |
| May 15, 2026 | Bozic Carmen | Sell | 1,354 | $453.45 | $614K |
| May 15, 2026 | Bunnage Mark E. | Sell | 33 | $453.45 | $14.96K |
| May 12, 2026 | Bozic Carmen | Sell | 6,988 | $450.00 | $3.14M |
| May 4, 2026 | Bhatia Sangeeta N. | Sell | 318 | $423.73 | $135K |
| May 1, 2026 | Bhatia Sangeeta N. | Other | 943 | — | — |
Source: SEC Form 4 filings. "Other" covers awards, option exercises and gifts.